Trade Summary

5 days ago, RA CAPITAL MANAGEMENT, L.P., serving as Dir at Artiva Biotherapeutics, Inc. (ARTV), purchased 264,586 shares at $9.76 per share, for a total transaction value of $2,583,314.22. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 17,242,483 shares of ARTV.

This purchase represents a 1.56% increase in RA CAPITAL MANAGEMENT, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, July 21, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 24, 2026 (accepted Jul 23, 9:22 PM ET), 3 days after the trade was made.

Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.